KKR, TPG Capital and Apax Partners are among private equity firms that are evaluating a purchase of India’s largest cardiac stent maker Sahajanand Medical Technologies (SMT), valuing the company at about 3,500-4,000 crore, said people in the know. Morgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias, the company’s promoters, own the remaining 45%.
Read the full article: Operation Buyout: KKR, TPG, and Other PE Firms Eye Purchase of India’s Largest Cardiac Stent Maker SMT //
Source: https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/operation-buyout-kkr-tpg-and-other-pe-firms-eye-purchase-of-indias-largest-cardiac-stent-maker-smt/articleshow/112634737.cms